Literature DB >> 29493331

Characterization of Hb Bart's Hydrops Fetalis Caused by - -SEA and a Large Novel α0-Thalassemia Deletion.

Sheng He1, Jihui Li2, Peng Huang1, Shujie Zhang1, Li Lin1, Yangjin Zuo1, Xiaoxian Tian1, Chenguang Zheng1, Xiaoxia Qiu1, Biyan Chen1.   

Abstract

Hb Bart's hydrops fetalis is the most severe and generally fatal clinical phenotype of α-thalassemia (α-thal), which is due to the deletion of all four functional α-globin genes of hemoglobin (Hb), resulting in no α-globin chain production (- -/- -). Homozygosity for the - -SEA (Southeast Asian) α-globin gene deletion is the main cause of the Hb Bart's hydrops fetalis in Asia, especially South China. Occasionally, other α0-thal deletions can also be found. In this study, we report a case with an atypical form of Hb Bart's hydrops fetalis that was caused by - -SEA and a large novel α0-thal deletion (- -GX) (Guangxi). The fetus with Hb Bart's in our study presented fetal hydrops features in early gestation which was different from that of traditional Hb Bart's hydrops fetalis with a homozygous - -SEA deletion. The early onset of fetal hydrops is attributed to the decreased formation of embryonic Hb Portland (ζ2γ2), which is proposed as a candidate for reactivation in cases of severe α-thal. Our findings indicated that it was important to characterize new or rare mutations, and highlighted the significance of using ultrasonography to identify signs of Hb Bart's hydrops fetalis.

Entities:  

Keywords:  Hb Bart’s hydrops fetalis; ultrasound; α-Globin gene; α-thalassemia (α-thal)

Mesh:

Substances:

Year:  2018        PMID: 29493331     DOI: 10.1080/03630269.2018.1434198

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  1 in total

1.  Characterisation of two unusual cases of haemoglobin Bart's hydrops foetalis caused by -SEA and large novel α-globin gene cluster deletions.

Authors:  Yunan Wang; Ying Xiong; Chang Liu; Jian Lu; Jicheng Wang; DanQing Qin; Ling Liu; Jing Wu; Xin Zhao; Liyuan Fang; Li Du; Aihua Yin
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.